K.V. Vimalnath

On the practical aspects of large-scale production of 177Lu for peptide receptor radionuclide therapy using direct neutron activation of 176Lu in a medium flux research reactor: the Indian experience

Sudipta Chakraborty, K.V. Vimalnath, Sharad P. Lohar et al. · Journal of Radioanalytical and Nuclear Chemistry · 2014 · 51 citations

Medicine, Nuclear Engineering, Nuclear Medicine +17

Preparation and evaluation of a new radiopharmaceutical for radiosynovectomy, 111Ag-labelled hydroxyapatite (HA) particles

Sankha Chattopadhyay, K.V. Vimalnath, Sujata Saha et al. · Applied Radiation and Isotopes · 2007 · 31 citations

Medicine, Oncology, Radiology +14

Radiolanthanide-loaded agglomerated Fe₃O₄nanoparticles for possible use in the treatment of arthritis: formulation, characterization and evaluation in rats

Sudipta Chakraborty, K. Sharma, A. Rajeswari et al. · Journal of Materials Chemistry B · 2015 · 29 citations · Full text

Pharmacy, Chemistry, Nuclear Medicine +17

Preparation, evaluation, and first clinical use of ¹⁷⁷Lu‐labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy

Sudipta Chakraborty, K.V. Vimalnath, A. Rajeswari et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2014 · 28 citations

Medicine, Nuclear Medicine, Nuclear Pharmacy +17

Prospects of medium specific activity ¹⁷⁷Lu in targeted therapy of prostate cancer using ¹⁷⁷Lu‐labeled PSMA inhibitor

Sudipta Chakraborty, Rubel Chakravarty, Priyalata Shetty et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2016 · 27 citations

Medicine, Pharmaceutics, Pharmacology +17